Effect of dietary pristane and other saturated mineral oils (MOSH) on autoimmune arthritis in rats

Monica Andreassen1, Hege Hjertholm1, Jean-Pierre Cravedi2

  • 1Norwegian Institute of Public Health, PO Box 4404, NO-0403 Oslo, Norway.

Toxicology Reports
|September 30, 2017
PubMed

Insights

Dietary exposure to mineral oil saturated hydrocarbons (MOSH), including pristane, did not induce autoimmune arthritis in rats. This suggests that oral MOSH intake has a low capacity to promote autoimmune disease development.

Area of Science:

  • Toxicology
  • Immunology
  • Rheumatology

Background:

  • Mineral oil saturated hydrocarbons (MOSH), such as pristane, are known to induce autoimmunity in rodents via intradermal injection.
  • Limited data exists regarding the immunological effects of oral MOSH exposure.

Purpose of the Study:

  • To investigate the impact of dietary exposure to pristane and other MOSH on the development of autoimmune arthritis.
  • To assess potential changes in serum and splenocyte markers associated with arthritis.

Main Methods:

  • Dark Agouti (DA) rats were fed diets containing pristane or a MOSH mixture for 90 days.
  • A positive control group received an intradermal injection of pristane.
  • Arthritis scores and immunological markers in serum and splenocytes were evaluated.

Main Results:

  • Rats receiving intradermal pristane injections developed arthritis and showed elevated serum markers.
  • No arthritis symptoms or significant changes in measured arthritis-associated biomarkers were observed in rats fed pristane or MOSH.
  • Dietary MOSH exposure did not induce clinical or serological signs of autoimmune arthritis.

Conclusions:

  • Sub-chronic dietary exposure to pristane or a broad MOSH mixture does not appear to promote the development of autoimmune arthritis in rats.
  • These findings suggest that oral MOSH intake has a low capacity to induce autoimmunity compared to intradermal administration.

Related Concept Videos